Evidence map›Paper›PMID 24456927›Full record

ArticleJournal of clinical bioinformatics2014

Combined analysis of chromosomal instabilities and gene expression for colon cancer progression inference.

Claudia Cava, Italo Zoppis, Manuela Gariboldi, Isabella Castiglioni, Giancarlo Mauri, Marco Antoniotti

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical bioinformatics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Claudia Cava *Institute of Molecular Bioimaging and Physiology of the National Research Council (IBFM-CNR), LITA Building - Via F.lli Cervi 93, 20090 Segrate (MI), Italy.
Italo Zoppis *Dipartimento di Informatica, Sistemistica e Comunicazione, Università degli Studi di Milano Bicocca, Viale Sarca 336, U14, 20126 Milan, Italy.
Manuela GariboldiDepartment of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Isabella CastiglioniInstitute of Molecular Bioimaging and Physiology of the National Research Council (IBFM-CNR), LITA Building - Via F.lli Cervi 93, 20090 Segrate (MI), Italy.
Giancarlo MauriDipartimento di Informatica, Sistemistica e Comunicazione, Università degli Studi di Milano Bicocca, Viale Sarca 336, U14, 20126 Milan, Italy.
Marco AntoniottiDipartimento di Informatica, Sistemistica e Comunicazione, Università degli Studi di Milano Bicocca, Viale Sarca 336, U14, 20126 Milan, Italy.
University of Milano-Bicocca · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITInstitute of Molecular Bioimaging and Physiology · ITNational Academies of Sciences, Engineering, and Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCopy number alterations (CNAs) represent an important component of genetic variations. Such alterations are related with certain type of cancer including those of the pancreas, colon, and breast, among others. CNAs have been used as biomarkers for cancer prognosis in multiple studies, but few works report on the relation of CNAs with the disease progression. Moreover, most studies do not consider the following two important issues. (I) The identification of CNAs in genes which are responsible for expression regulation is fundamental in order to define genetic events leading to malignant transformation and progression. (II) Most real domains are best described by structured data where instances of multiple types are related to each other in complex ways.

resultsOur main interest is to check whether the colorectal cancer (CRC) progression inference benefits when considering both (I) the expression levels of genes with CNAs, and (II) relationships (i.e. dissimilarities) between patients due to expression level differences of the altered genes. We first evaluate the accuracy performance of a state-of-the-art inference method (support vector machine) when subjects are represented only through sets of available attribute values (i.e. gene expression level). Then we check whether the inference accuracy improves, when explicitly exploiting the information mentioned above. Our results suggest that the CRC progression inference improves when the combined data (i.e. CNA and expression level) and the considered dissimilarity measures are applied.

conclusionsThrough our approach, classification is intuitively appealing and can be conveniently obtained in the resulting dissimilarity spaces. Different public datasets from Gene Expression Omnibus (GEO) were used to validate the results.

Identifiers

PMID24456927
PMCPMC3931674
OpenAlexW2120911337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.